ClinicalTrials.govpublic full text
An Investigation Of The Interaction Of GSK961081 With Inhaled Beta-Agonist And Anti-Muscarinic Drugs.
pulmonary disease, chronic obstructive, salbutamol,, chronic obstructive pulmonary disease (copd), gsk961081 muscarinic receptor antagonist,, copd, ipratropium bromide,, asthma, ß2-adrenergic agonist,, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 827071
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.